Ignite Creation Date:
2024-05-05 @ 4:53 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00332176
Status:
UNKNOWN
Last Update Posted:
2008-04-08
First Post:
2006-05-30
Brief Title:
A Study to Evaluate the Safety Antiviral Effect and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
Sponsor:
BioWest Therapeutics Inc
Organization:
BioWest Therapeutics Inc
Organization Data
Organization:
BioWest Therapeutics Inc
Class:
INDUSTRY
Study ID:
HCV-06-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioWest Therapeutics Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Jim Pankovich Study Director
Old Organization:
MIGENIX Inc